🇮🇱 RYZNEUTA in Israel

RYZNEUTA (EFBEMALENOGRASTIM ALFA-VUXW) regulatory status in Israel.

Marketing authorisation

MOH

  • Status: likely_approved

RYZNEUTA in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in Israel

Frequently asked questions

Is RYZNEUTA approved in Israel?

Yes. MOH has authorised it.

Who is the marketing authorisation holder for RYZNEUTA in Israel?

EVIVE BIOTECHNOLOGY is the originator. The local marketing authorisation holder may differ — check the official source linked above.